PH15118A - Octahydro-2h-pyrrolo(3-4-g)quinolines pharmaceutical composition containing same - Google Patents

Octahydro-2h-pyrrolo(3-4-g)quinolines pharmaceutical composition containing same

Info

Publication number
PH15118A
PH15118A PH22695A PH22695A PH15118A PH 15118 A PH15118 A PH 15118A PH 22695 A PH22695 A PH 22695A PH 22695 A PH22695 A PH 22695A PH 15118 A PH15118 A PH 15118A
Authority
PH
Philippines
Prior art keywords
quinolines
octahydro
pyrrolo
pharmaceutical composition
composition containing
Prior art date
Application number
PH22695A
Other languages
English (en)
Inventor
Nicholas James Bach
Edmund Carl Kornfeld
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/031,642 external-priority patent/US4235909A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH15118A publication Critical patent/PH15118A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH22695A 1979-01-22 1979-06-27 Octahydro-2h-pyrrolo(3-4-g)quinolines pharmaceutical composition containing same PH15118A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US506279A 1979-01-22 1979-01-22
US06/031,642 US4235909A (en) 1979-04-19 1979-04-19 Octahydro-2H-pyrrolo[3,4-g]quinolines

Publications (1)

Publication Number Publication Date
PH15118A true PH15118A (en) 1982-08-10

Family

ID=26673871

Family Applications (2)

Application Number Title Priority Date Filing Date
PH22695A PH15118A (en) 1979-01-22 1979-06-27 Octahydro-2h-pyrrolo(3-4-g)quinolines pharmaceutical composition containing same
PH24086A PH16181A (en) 1979-01-22 1980-05-29 Octahydro-2h-pyrrolo(3,4-g)quinolines

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH24086A PH16181A (en) 1979-01-22 1980-05-29 Octahydro-2h-pyrrolo(3,4-g)quinolines

Country Status (25)

Country Link
EP (1) EP0013788B1 (fi)
JP (1) JPS55100385A (fi)
AR (1) AR225012A1 (fi)
AT (1) AT365189B (fi)
AU (1) AU528035B2 (fi)
BE (1) BE877328A (fi)
CA (1) CA1131227A (fi)
CH (2) CH641801A5 (fi)
DD (1) DD144668A5 (fi)
DE (1) DE2965277D1 (fi)
DK (1) DK268979A (fi)
ES (1) ES482084A1 (fi)
FI (1) FI65248C (fi)
FR (2) FR2446833A1 (fi)
GB (1) GB2040917B (fi)
IE (1) IE48295B1 (fi)
IL (1) IL57665A (fi)
LU (1) LU81440A1 (fi)
NZ (1) NZ190834A (fi)
PH (2) PH15118A (fi)
PL (1) PL125785B1 (fi)
PT (1) PT69828A (fi)
RO (1) RO77442A (fi)
SU (1) SU1113006A3 (fi)
ZA (1) ZA793244B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65269A0 (en) * 1981-03-24 1982-05-31 Lilly Co Eli 6-substituted hexahydroindazolo or hexahydroisoindolo isoquinolines
DE3373468D1 (de) * 1983-06-03 1987-10-15 Lilly Co Eli Trans-dl-1-alkyl-6-alkoxyoctahydroquinolines
IL73001A0 (en) * 1983-09-26 1984-12-31 Lilly Co Eli Improvements in and relating to 6-oxodecahydroquinolines
US4595754A (en) * 1985-03-04 1986-06-17 Eli Lilly And Company Process for preparing cis N-alkylperhydroquinolines
AR067027A1 (es) * 2007-06-19 2009-09-30 Astrazeneca Ab Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a.
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途

Also Published As

Publication number Publication date
ATA452579A (de) 1981-05-15
EP0013788A1 (en) 1980-08-06
DE2965277D1 (en) 1983-06-01
PH16181A (en) 1983-07-25
ES482084A1 (es) 1980-08-01
JPS55100385A (en) 1980-07-31
BE877328A (fr) 1979-12-28
FI65248B (fi) 1983-12-30
AR225012A1 (es) 1982-02-15
GB2040917B (en) 1983-01-06
IE48295B1 (en) 1984-11-28
PT69828A (en) 1979-07-01
FR2446835A1 (fr) 1980-08-14
EP0013788B1 (en) 1983-04-27
DK268979A (da) 1980-07-23
PL125785B1 (en) 1983-06-30
PL216721A1 (fi) 1980-06-16
IL57665A0 (en) 1979-10-31
IL57665A (en) 1982-11-30
CH643258A5 (fr) 1984-05-30
FR2446833B1 (fi) 1982-03-05
AU528035B2 (en) 1983-04-14
JPS6233233B2 (fi) 1987-07-20
FR2446835B1 (fi) 1982-04-23
GB2040917A (en) 1980-09-03
AU4844479A (en) 1980-07-31
FI792047A (fi) 1980-07-23
ZA793244B (en) 1981-02-25
NZ190834A (en) 1984-07-06
RO77442A (ro) 1982-10-26
DD144668A5 (de) 1980-10-29
LU81440A1 (fr) 1979-09-12
FI65248C (fi) 1984-04-10
SU1113006A3 (ru) 1984-09-07
CA1131227A (en) 1982-09-07
FR2446833A1 (fr) 1980-08-14
CH641801A5 (fr) 1984-03-15
IE791210L (en) 1980-10-19
AT365189B (de) 1981-12-28

Similar Documents

Publication Publication Date Title
IL60555A0 (en) Pharmaceutical compositions containing certain ureal derivatives
PH17194A (en) Novel carbostyril derivatives,and pharmaceutical composition containing the same
IL61375A0 (en) Chloro and alkoxy-substituted-2,4-diaminoquinazolines and pharmaceutical compositions containing them
PT73959B (en) Process for preparing carbostyril compounds and pharmaceutical compositions containing the same
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
IL63423A0 (en) 9-amino-1-hydroxyoctahydrobenzo(c)quinoline derivatives and pharmaceutical compositions containing them
DE3072103D1 (en) Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
GB2046259B (en) Amino-alcohol derivatives and pharmaceutical compositions containing them
PH16443A (en) Substituted tetraazetricyclic compounds and their pharmaceutical compositions
IL61264A (en) Dihydro-piperazinylpyrazolobenzodiazepine compounds,their preparation and pharmaceutical compositions containing them
IL60472A (en) Substituted heterocyclic phenoxyamines,their preparation and pharmaceutical compositions containing them
IL61117A0 (en) Acetoxymethyl-penem compounds and pharmaceutical compositions containing them
IL60376A (en) 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them
DE3069831D1 (en) 2-pyridyl chromans and pharmaceutical compositions containing them
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
ZA805666B (en) Pharmaceutical compositions containing paracetamol
PH18532A (en) Novel carbostyril derivatives and pharmaceutical compositions containing the same
PH15118A (en) Octahydro-2h-pyrrolo(3-4-g)quinolines pharmaceutical composition containing same
IL60700A0 (en) 25-halocholest-5-ene-2 ,22-diols and esters thereof and pharmaceutical compositions containing them
IL60813A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
DE3064666D1 (en) Pharmaceutical compositions containing paracetamol
ZA806383B (en) Long acting pharmaceutical composition
EP0018077A3 (en) Phenylmorphans, processes for their preparation, pharmaceutical compositions containing them, and 4-phenyl-tetrahydro-pyridines
PH16754A (en) Novel acylamino-benzazole derivatives,and pharmaceutical composition containing same